SCPC to Congress: Fix conflicting oversight and definitions of ‘LTC pharmacy’
Published by Long-Term Living Magazine
The Senior Care Pharmacy Coalition (SCPC) wants Congress to iron out the complex maze of federal and state regulations and policies governing long-term care (LTC) pharmacies, warning that differing definitions and overlapping jurisdictions may jeopardize seniors’ access to quality care coordination.
Growing roles for LTC pharmacies and the evolving payment landscape have complicated the reporting and procedural regulations for maintaining supply and delivery, according to an SCPC policy brief.
The Centers for Medicare and Medicaid Services (CMS), the U.S. Food and Drug Administration (FDA), the Environmental Protection Agency and other federal entities all have different definitions of an LTC pharmacy and different regulations concerning drug repackaging, emergency drug distribution, drug disposal and utilization tracking. Without some sort of consensus, the SCPC contends, “the FDA Guidance [on repackaging] puts patient care at risk by imposing requirements on LTC pharmacies directly conflicting with CMS requirements.”
Crafting better definitions and oversight of LTC pharmacies means acknowledging the unique role they play in the healthcare continuum. “LTC pharmacies have played an essential role not only in providing timely and emergency dispensing of medication, but also in fulfilling key nursing facility obligations to perform drug regimen reviews and more recently medication therapy management,” the policy brief notes. “Over the decades, CMS has acknowledged the key role that LTC pharmacy fills in the LTC ecosystem, and specifically in providing medication services to nursing homes and their residents.”
The SCPC even hints at a rating system for pharmacies similar to the Nursing Home Compare system: “To operate within this emerging new environment, LTC pharmacy will have to demonstrate the value of its services–both to earn its compensation, and to develop and satisfy appropriate metrics to demonstrate it is a quality provider,” the policy brief adds. “A pharmacy ‘star rating’ system may emerge by which pharmacies, like nursing homes, can be measured by payers and intermediaries.”
Click here to see the original article on the Long-Term Living Magazine website.
Recent Posts
-
House Lawmakers Push Bipartisan IRA Fix To Boost LTC Pharmacy Pay
A bipartisan group of House lawmakers introduced legislation aimed at ensuring long-term care (LTC) pharmacies are paid an adequate supply fee to maintain patient access to prescription drugs for which prices are lowered through the Medicare drug price negotiation program, with the new maximum fair prices (MFPs) for the first group of selected drugs to take effect at the start of 2026.
-
Bill would fix drug-negotiation pricing flaw that undercuts LTC pharmacists’ viability
Lawmakers have proposed a supply fee to bolster long-term care pharmacies facing major revenue losses with the implementation of negotiated prices on 10 commonly prescribed medications Jan. 1.
The Preserving Patient Access to Long-Term Pharmacies Act establishes a $30 per Medicare Part D prescription in 2026 and 2027.
-
Rep. Van Duyne Introduces Bipartisan Legislation to Protect Seniors’ Access to Long-Term Care Pharmacies
Washington, D.C. – Representatives Beth Van Duyne (R-TX), Brad Schneider (D-IL), Buddy Carter (R-GA), Sharice Davids (D-KS), and Deborah Ross (D-NC) introduced H.R. 5031 Preserving Patient Access to Long-Term Care Pharmacies Act, bipartisan legislation to protect access to essential medications and pharmacy services for seniors and other long-term care (LTC) residents in nursing homes, assisted living, and similar […]
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.